The rating affirmation is based on a number of factors, including Rex’s strong operating performance, growing market share in a competitive market and adequate balance sheet metrics.
Rex also faces numerous challenges, including a high degree of leverage.
The outlook is stable, reflecting Moody’s Investors Service’s expectation that Rex will continue to generate solid cash flow margins and maintain adequate debt service coverage.
More articles on healthcare finance:
LifePoint gets revenue boost from acquisitions
Moody’s affirms Holy Redeemer Health System’s ‘Baa3’ rating
Moody’s affirms Fairview Health Services’ ‘A2’ rating
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
